Allschwil, Switzerland

Markus Britschgi

USPTO Granted Patents = 5 

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Markus Britschgi

Introduction

Markus Britschgi is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 5 patents to his name, Britschgi's work has the potential to impact various medical applications.

Latest Patents

Among his latest patents are the "Anti-alpha-synuclein antibodies and methods of use." This invention provides anti-human alpha-synuclein antibodies and outlines methods for utilizing these antibodies effectively. The focus on alpha-synuclein is crucial, as it is associated with neurodegenerative diseases, making this innovation particularly relevant in the medical field.

Career Highlights

Markus Britschgi is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to collaborate with other experts in the field, enhancing the development of innovative solutions in biotechnology.

Collaborations

Throughout his career, Britschgi has worked alongside notable colleagues such as Klaus Kaluza and Olaf Mundigl. These collaborations have fostered a productive environment for innovation and research, contributing to the advancement of their shared goals in biotechnology.

Conclusion

Markus Britschgi's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…